Literature DB >> 4945727

Responses of the rat foetus to maternal injections of adrenaline and vasopressin.

N Chernoff, C T Grabowski.   

Abstract

1. Injection of 0.5-2.0 units of vasopressin or 25-100 mug of adrenaline into the peritoneal cavity of pregnant rats produced a transient slowing of the foetal heart. The bradycardia could be induced in foetuses after 15-21 days of gestation. Foetal heart rates dropped from normal values of 140-180 beats/min, often to less than 20 beats/minute. The period of bradycardia was dose dependent and ranged from 30 to 65 minutes.2. Maternal injection of the hormones produced a fall in foetal blood pressure from an average of 54, often to less than 20 mm of water, in 17-day foetuses. Direct injection of the hormones into the pericardial sac of the foetuses had the opposite effect and pressures rose an average of 15 mm of water 1 min after the injection.3. During the period of bradycardia, the potassium concentrations in foetal serum rose from an average value of 8.9 mequiv/1. to an average of 17.3 mequiv/litre. Concentrations of serum sodium fell from 126.2 to 121.4 mequiv/1. during the bradycardia. No changes were detected in the concentrations of either calcium or chloride. Foetal P(O2) levels fell from 25 to 15, P(CO2) rose from 61 to 89 or more, and pH fell from 7.19 to 6.86 during the bradycardia.4. Maternal death and uterine clamping caused foetal bradycardia and a rise in foetal serum potassium to an average of 20.2 mequiv/litre.5. It is concluded that interruption of normal uterine blood flow by vasoconstruction (adrenaline or vasopressin) or direct blockage (uterine clamping) results in a transient hypoxia, bradycardia, and serum ion changes in foetuses.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4945727      PMCID: PMC1665874     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  The uterine vascular bed: effect of adrenergic stimulation.

Authors:  F C GREISS
Journal:  Obstet Gynecol       Date:  1963-03       Impact factor: 7.661

2.  Umbilical venous pressure and other cardiovascular responses of fetal lambs to epinephrine.

Authors:  S R REYNOLDS; J D MACKIE
Journal:  Am J Physiol       Date:  1962-11

3.  Response of human foetal heart and maternal circulation to adrenaline and noradrenaline.

Authors:  R W BEARD
Journal:  Br Med J       Date:  1962-02-17

4.  Uterine vascular clamping: new procedure for the study of congenital malformations.

Authors:  R L BRENT; J B FRANKLIN
Journal:  Science       Date:  1960-07-08       Impact factor: 47.728

5.  Some foetal blood-pressure reactions.

Authors:  G A Clark
Journal:  J Physiol       Date:  1932-04-26       Impact factor: 5.182

6.  Effect of drugs on the blood flow and activity of the uterus.

Authors:  J M Robson; H O Schild
Journal:  J Physiol       Date:  1938-02-16       Impact factor: 5.182

7.  Effects of angiotensin, oxytocin and vasopressin on placental circulation. An angiographic study in rabbits.

Authors:  A M Carter; J Göthlin
Journal:  Invest Radiol       Date:  1970 Mar-Apr       Impact factor: 6.016

8.  The effects of teratogenic doses of hypoxia on the blood pressure of chick embryos.

Authors:  C Grabowski; E N Tsai; H R Toben
Journal:  Teratology       Date:  1969-02

9.  Production of fetal asphyxia in the rhesus monkey by administration of catecholamines to the mother.

Authors:  K Adamsons; E Mueller-Heubach; R E Myers
Journal:  Am J Obstet Gynecol       Date:  1971-01-15       Impact factor: 8.661

10.  [The action of adrenaline and noradrenaline at the uterine and fetal level. Clinico-experimental observations].

Authors:  G Sani; L Giardina; M Angiolillo
Journal:  Riv Ital Ginecol       Date:  1966-03
View more
  1 in total

1.  Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.

Authors:  C Hicks; L Ramos; T Reekie; G H Misagh; R Narlawar; M Kassiou; I S McGregor
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.